v3.26.1
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Previously Reported
Reverse recapitalization
Common Stock
Common Stock
Previously Reported
Common Stock
Reverse recapitalization
Additional Paid-In Capital
Additional Paid-In Capital
Previously Reported
Additional Paid-In Capital
Reverse recapitalization
Accumulated Deficit
Accumulated Deficit
Previously Reported
Accumulated Deficit
Reverse recapitalization
Accumulated Comprehensive Income (Loss)
Accumulated Comprehensive Income (Loss)
Previously Reported
Accumulated Comprehensive Income (Loss)
Reverse recapitalization
Beginning balance (in shares) at Dec. 31, 2024 62,240 93,963 (31,723)                        
Beginning balance at Dec. 31, 2024 $ 170,648 $ 170,648 $ 0                        
Ending balance (in shares) at Mar. 31, 2025 62,240                            
Ending balance at Mar. 31, 2025 $ 170,648                            
Beginning balance (in shares) at Dec. 31, 2024       58,057 87,646 (29,589)                  
Beginning balance at Dec. 31, 2024 (250,835) $ (250,835) $ 0 $ 6 $ 0 $ 6 $ 17,303 $ 17,309 $ (6) $ (268,144) $ (268,144) $ 0 $ 0 $ 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon exercise of common stock warrants (in shares)       17                      
Issuance of common stock upon exercise of stock options (in shares)       942                      
Issuance of common stock upon exercise of stock options 508           508                
Stock-based compensation 1,878           1,878                
Net income (loss) (128,185)                 (128,185)          
Ending balance (in shares) at Mar. 31, 2025       59,016                      
Ending balance at Mar. 31, 2025 $ (376,634)     $ 6     19,689     (396,329)     0    
Beginning balance (in shares) at Dec. 31, 2024 62,240 93,963 (31,723)                        
Beginning balance at Dec. 31, 2024 $ 170,648 $ 170,648 $ 0                        
Ending balance (in shares) at Jun. 30, 2025 62,240                            
Ending balance at Jun. 30, 2025 $ 170,648                            
Beginning balance (in shares) at Dec. 31, 2024       58,057 87,646 (29,589)                  
Beginning balance at Dec. 31, 2024 (250,835) $ (250,835) $ 0 $ 6 $ 0 $ 6 17,303 $ 17,309 $ (6) (268,144) $ (268,144) $ 0 0 $ 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) (241,911)                            
Ending balance (in shares) at Jun. 30, 2025       59,742                      
Ending balance at Jun. 30, 2025 $ (486,919)     $ 6     23,130     (510,055)     0    
Beginning balance (in shares) at Mar. 31, 2025 62,240                            
Beginning balance at Mar. 31, 2025 $ 170,648                            
Ending balance (in shares) at Jun. 30, 2025 62,240                            
Ending balance at Jun. 30, 2025 $ 170,648                            
Beginning balance (in shares) at Mar. 31, 2025       59,016                      
Beginning balance at Mar. 31, 2025 (376,634)     $ 6     19,689     (396,329)     0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon exercise of stock options (in shares)       726                      
Issuance of common stock upon exercise of stock options 428           428                
Stock-based compensation 3,013           3,013                
Net income (loss) (113,726)                 (113,726)          
Ending balance (in shares) at Jun. 30, 2025       59,742                      
Ending balance at Jun. 30, 2025 $ (486,919)     $ 6     23,130     (510,055)     0    
Ending balance (in shares) at Sep. 24, 2025 174,957                            
Beginning balance (in shares) at Dec. 31, 2025 142                            
Beginning balance at Dec. 31, 2025 $ 223,185                            
Ending balance (in shares) at Mar. 31, 2026 142                            
Ending balance at Mar. 31, 2026 $ 223,185                            
Beginning balance (in shares) at Dec. 31, 2025 175,440     175,440                      
Beginning balance at Dec. 31, 2025 $ (283,052)     $ 17     570,578     (853,669)     22    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon exercise of common stock warrants (in shares)       386                      
Issuance of common stock upon exercise of common stock warrants 3,584           3,584                
Issuance of common stock upon exercise of stock options (in shares)       1,650                      
Issuance of common stock upon exercise of stock options 973     $ 1     972                
Stock-based compensation 6,111           6,111                
Other comprehensive loss (24)                       (24)    
Net income (loss) 26,490                 26,490          
Ending balance (in shares) at Mar. 31, 2026       177,476                      
Ending balance at Mar. 31, 2026 $ (245,918)     $ 18     581,245     (827,179)     (2)    
Beginning balance (in shares) at Dec. 31, 2025 142                            
Beginning balance at Dec. 31, 2025 $ 223,185                            
Ending balance (in shares) at Jun. 30, 2026 142                            
Ending balance at Jun. 30, 2026 $ 223,185                            
Beginning balance (in shares) at Dec. 31, 2025 175,440     175,440                      
Beginning balance at Dec. 31, 2025 $ (283,052)     $ 17     570,578     (853,669)     22    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon exercise of stock options (in shares) 2,368                            
Net income (loss) $ 38,967                            
Ending balance (in shares) at Jun. 30, 2026 194,173     194,173                      
Ending balance at Jun. 30, 2026 $ (188,918)     $ 19     625,883     (814,702)     (118)    
Beginning balance (in shares) at Mar. 31, 2026 142                            
Beginning balance at Mar. 31, 2026 $ 223,185                            
Ending balance (in shares) at Jun. 30, 2026 142                            
Ending balance at Jun. 30, 2026 $ 223,185                            
Beginning balance (in shares) at Mar. 31, 2026       177,476                      
Beginning balance at Mar. 31, 2026 (245,918)     $ 18     581,245     (827,179)     (2)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon exercise of common stock warrants (in shares)       594                      
Issuance of common stock upon exercise of common stock warrants 3,563           3,563                
Issuance of common stock and warrants in connection with a private placement, net of transaction costs (in shares)       15,385                      
Issuance of common stock and warrants in connection with a private placement, net of transaction costs 34,126     $ 1     34,125                
Issuance of common stock upon exercise of stock options (in shares)       718                      
Issuance of common stock upon exercise of stock options 469           469                
Stock-based compensation 6,481           6,481                
Other comprehensive loss (116)                       (116)    
Net income (loss) $ 12,477                 12,477          
Ending balance (in shares) at Jun. 30, 2026 194,173     194,173                      
Ending balance at Jun. 30, 2026 $ (188,918)     $ 19     $ 625,883     $ (814,702)     $ (118)